Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 9 studies | 27% ± 13% | |
endothelial cell | 7 studies | 27% ± 9% | |
epithelial cell | 6 studies | 27% ± 8% | |
microglial cell | 5 studies | 22% ± 5% | |
ciliated cell | 5 studies | 22% ± 5% | |
oligodendrocyte | 5 studies | 24% ± 6% | |
dendritic cell | 5 studies | 16% ± 0% | |
GABAergic neuron | 4 studies | 34% ± 16% | |
fibroblast | 4 studies | 22% ± 6% | |
macrophage | 4 studies | 31% ± 9% | |
glutamatergic neuron | 3 studies | 45% ± 16% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 9% | |
abnormal cell | 3 studies | 23% ± 6% | |
alveolar macrophage | 3 studies | 28% ± 9% | |
endothelial cell of lymphatic vessel | 3 studies | 19% ± 2% | |
monocyte | 3 studies | 24% ± 4% | |
goblet cell | 3 studies | 35% ± 17% | |
transit amplifying cell | 3 studies | 25% ± 13% | |
interneuron | 3 studies | 44% ± 21% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 37% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 6061.06 | 1445 / 1445 | 100% | 51.79 | 183 / 183 |
lung | 100% | 6333.75 | 578 / 578 | 100% | 47.57 | 1155 / 1155 |
prostate | 100% | 5956.92 | 245 / 245 | 100% | 61.72 | 502 / 502 |
stomach | 100% | 4275.58 | 359 / 359 | 100% | 40.56 | 286 / 286 |
brain | 100% | 5521.27 | 2641 / 2642 | 100% | 53.46 | 705 / 705 |
breast | 100% | 5256.80 | 459 / 459 | 100% | 65.15 | 1117 / 1118 |
intestine | 100% | 5864.05 | 966 / 966 | 100% | 42.79 | 526 / 527 |
uterus | 100% | 6534.82 | 170 / 170 | 100% | 40.53 | 457 / 459 |
thymus | 100% | 8517.49 | 653 / 653 | 100% | 55.99 | 602 / 605 |
skin | 100% | 7324.35 | 1809 / 1809 | 99% | 48.19 | 469 / 472 |
kidney | 100% | 4662.37 | 89 / 89 | 99% | 45.16 | 894 / 901 |
bladder | 100% | 5434.00 | 21 / 21 | 99% | 36.86 | 499 / 504 |
ovary | 100% | 4928.85 | 180 / 180 | 99% | 31.93 | 425 / 430 |
pancreas | 100% | 2983.99 | 327 / 328 | 99% | 41.82 | 176 / 178 |
adrenal gland | 100% | 5636.98 | 258 / 258 | 96% | 43.31 | 221 / 230 |
liver | 100% | 2449.73 | 226 / 226 | 89% | 20.30 | 363 / 406 |
adipose | 100% | 5173.66 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6817.12 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 20.47 | 29 / 29 |
spleen | 100% | 4748.56 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 52.94 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 15.24 | 1 / 1 |
muscle | 100% | 3627.86 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 3674.81 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 42.40 | 78 / 80 |
peripheral blood | 91% | 2888.39 | 842 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0072583 | Biological process | clathrin-dependent endocytosis |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030136 | Cellular component | clathrin-coated vesicle |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005769 | Cellular component | early endosome |
GO_0032050 | Molecular function | clathrin heavy chain binding |
Gene name | GPR107 |
Protein name | G protein-coupled receptor 107 Protein GPR107 (Lung seven transmembrane receptor 1) GPR107 protein |
Synonyms | hCG_1810895 KIAA1624 LUSTR1 |
Description | FUNCTION: Has been proposed to act as a receptor for neuronostatin, a peptide derived from the somatostatin/SST precursor . Involved in blood sugar regulation through the induction of glucagon in response to low glucose (By similarity). .; FUNCTION: (Microbial infection) Required for intoxication by Pseudomonas aeruginosa exotoxin A and Campylobacter jejuni CDT. May contribute to the retrograde transport of bacterial toxins, including cholera toxin, from the trans-Golgi network to the endoplasmic reticulum. . |
Accessions | B7ZL93 ENST00000347136.11 [Q5VW38-2] G5E994 U3KQD2 Q5VW38 ENST00000372406.5 [Q5VW38-1] ENST00000493417.5 ENST00000372410.7 |